Brief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
23/10/2026 23:20
BRIEF-AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4) Oct 23 (Reuters) - AN2 Therapeutics Inc ANTX.O:
AN2 THERAPEUTICS, INC. REPORTS INDUCEMENT GRANTS UNDER LISTING RULE 5635(C)(4)
Source text: ID:nBw62t868a
Further company coverage: ANTX.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview